Sign in
4

Changes in Ownership

Merck & Co., Inc. Filed Acc 0001127602-21-028263

EVP, Chief Patient Officer sold 96,270 shares at $87.91 ($8,462,682)

  • EVP, Chief Patient Officer acquired 96,270 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gerberding Julie L. · EVP, Chief Patient Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-01 Exercise or conversion : show line 1 in the form +35,287 74,449.14 D
2021-11-01 Exercise or conversion : show line 2 in the form +30,175 104,624.14 D
2021-11-01 Exercise or conversion : show line 3 in the form +19,394 124,018.14 D
2021-11-01 Exercise or conversion : show line 4 in the form +11,414 135,432.14 D
2021-11-01 Sale : show line 5 in the form −96,270 $87.91 $8,462,682 39,162.14 D
Open-market sales · 96,270 sh · avg $87.91 · $8,462,682

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-11-01 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −35,287 0 D
2021-11-01 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −30,175 0 D
2021-11-01 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −19,394 9,698 D
2021-11-01 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −11,414 22,831 D
Loading xslF345X03/form4.xml…